Table 3
Treatment-related adverse events
| Adverse events | Any grade No.(%) | Grade 1/2 No.(%) | Grade 3/4 No.(%) |
|---|---|---|---|
| Any | 9 (60.0) | 7 | 2 |
| Mouth ulcer | 5 (33.3) | 4 | 1 |
| Elevated liver enzymes | 2 (13.3) | 2 | 0 |
| Dyslipidemia | 1 (6.67) | 1 | 0 |
| Maculopapule | 1 (6.67) | 0 | 1 |
Treatment-related adverse events
| Adverse events | Any grade No.(%) | Grade 1/2 No.(%) | Grade 3/4 No.(%) |
|---|---|---|---|
| Any | 9 (60.0) | 7 | 2 |
| Mouth ulcer | 5 (33.3) | 4 | 1 |
| Elevated liver enzymes | 2 (13.3) | 2 | 0 |
| Dyslipidemia | 1 (6.67) | 1 | 0 |
| Maculopapule | 1 (6.67) | 0 | 1 |